Target intelligence / Profile preview

RNA, U6atac small nuclear 32, pseudogene (RNU6ATAC32P)

Target
RNU6ATAC32P
Molecular classification
Other (pseudogene, non-coding RNA family)
01

Overview

RNU6ATAC32P is classified as a pseudogene related to the small nuclear RNA known as U6atac, but does not produce a functional protein or snRNA[3]. RNU6ATAC32P is a processed pseudogene derived from the U6atac small nuclear RNA gene, annotated in the human genome (HGNC: 46931, NCBI Gene: 106479556, Ensembl: ENSG00000251835)[3]. The U6atac snRNA is part of the minor spliceosome, responsible for catalyzing the removal of rare “minor” introns in a select group of highly conserved genes, playing a role in post-transcriptional gene regulation and cell response to stress[1]. However, RNU6ATAC32P is not itself a functional RNA and does not contribute to minor spliceosome activity; it exists in the genome as a non-functional, duplicated sequence. Pseudogenes like RNU6ATAC32P do not typically serve as drug targets or biomarkers. There is no evidence supporting RNU6ATAC32P involvement in cellular processes, disease mechanisms, or as a therapeutic target[3][4].

Other names
RNU6ATAC32P
02

Biological functions

None established; pseudogenes sometimes regulate parental gene expression via miRNA competition or endogenous siRNA sources, but no function is documented for RNU6ATAC32P[2][4].
03

Disease associations

None established; pseudogenes may participate in regulatory roles in cancer or other diseases, but no specific disease association for RNU6ATAC32P[4].

Beyond the preview

Go deeper on RNA, U6atac small nuclear 32, pseudogene (RNU6ATAC32P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6atac small nuclear 32, pseudogene (RNU6ATAC32P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call